{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:47:14Z","timestamp":1784130434076,"version":"3.55.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"EMSTAR","award":["22\/060"],"award-info":[{"award-number":["22\/060"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Atypical Parkinsonian Syndromes (APS) form the third largest group of neurodegenerative disorders including Progressive Supranuclear Palsy (PSP), Multiple System Atrophy (MSA), and Corticobasal Syndrome (CBS). These conditions are characterized by rapid progression, poor prognosis, low survival rates, and limited treatment options. Few studies have suggested that genetic, environmental factors and inflammation contribute to the pathobiology of these complex disorders, however, the etiology of disease and progression remains unclear.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A multicenter prospective longitudinal (3-time point) study will be conducted with a total sample size of 400 across all the groups (PSP, MSA, CBS). Patients with APS will be recruited after a detailed evaluation by movement disorder specialists and obtaining valid informed consent. The socio-demographic data and\u00a0whole exome sequencing will be performed only at the baseline. Non-invasive procedures such as neurological and cognitive assessments, sleep quality assessments including polysomnography, brain imaging, and retinal imaging will be conducted at each time point. In addition, gene expressions, methylation patterns, inflammatory cytokines, disease-associated pathological proteins (Tau, pTau-181, \u03b1-synuclein and \u03b2-amyloid), non-targeted proteomics, skin biopsy, and iPSC will be performed at each time point eventually. The statistical analysis will be performed, followed by the developing of machine learning (ML) models.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Expected outcomes and conclusion<\/jats:title>\n<jats:p>This unique native dataset in APS will enhance our understanding of the molecular mechanisms driving pathological protein aggregation and disease progression. Furthermore, the longitudinal design of the study enables a detailed examination of symptom development, progression, and management. The ML models combined with advanced imaging techniques will aid in early diagnosis, differentiation among APS types, and the development of future clinical trials and treatment strategies.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0325624","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T17:24:11Z","timestamp":1750958651000},"page":"e0325624","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Progression and natural history of Atypical Parkinsonism (ATPARK): Protocol for a longitudinal follow-up study from an underrepresented population"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8016-9089","authenticated-orcid":true,"given":"Ravi","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saikat","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravichandiran","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athira P.","family":"Mohanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geethu T.","family":"Vasudevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manasi","family":"Harish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7933-8826","authenticated-orcid":true,"given":"Nitish","family":"Kamble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram V.","family":"Holla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan R.","family":"Mahale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Mailankody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5843-072X","authenticated-orcid":true,"given":"Monojit","family":"Debnath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitender","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0343-224X","authenticated-orcid":true,"given":"Keshav","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Mahadevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarada","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phalguni","family":"Alladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indrani","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binu V.","family":"Sreekumarannair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Stezin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhura","family":"Ingalhalikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8888-4661","authenticated-orcid":true,"given":"Sweta","family":"Ramdas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepthi R.","family":"Bathula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod Kumar","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,6,26]]},"reference":[{"key":"pone.0325624.ref001","first-page":"1117","article-title":"Diagnostic approach to atypical parkinsonian syndromes","volume":"22","author":"NR McFarland","year":"2016","journal-title":"Continuum (Minneap Minn)"},{"issue":"2","key":"pone.0325624.ref002","first-page":"169","article-title":"Epidemiology of atypical parkinsonian syndromes","volume":"34","author":"RY Lo","year":"2021","journal-title":"Tzu Chi Med J"},{"issue":"11","key":"pone.0325624.ref003","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.parkreldis.2014.07.017","article-title":"Diagnostic accuracy of Parkinson\u2019s disease and atypical parkinsonism in nursing homes","volume":"20","author":"NJ Weerkamp","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"pone.0325624.ref004","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-0037-1602422","article-title":"Recognizing Atypical Parkinsonisms: \u201cRed Flags\u201d and Therapeutic Approaches","volume":"37","author":"NR McFarland","year":"2017","journal-title":"Semin Neurol"},{"key":"pone.0325624.ref005","doi-asserted-by":"crossref","first-page":"101644","DOI":"10.1016\/j.pneurobio.2019.101644","article-title":"Four-repeat tauopathies","volume":"180","author":"TW R\u00f6sler","year":"2019","journal-title":"Prog Neurobiol"},{"issue":"6","key":"pone.0325624.ref006","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2990.2007.00907.x","article-title":"Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy","volume":"33","author":"Neuropathology Working Group on MSA.","year":"2007","journal-title":"Neuropathol Appl Neurobiol"},{"key":"pone.0325624.ref007","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/09727531221089396","article-title":"Genetic and Epigenetic Constructs of Progressive Supranuclear Palsy","volume":"29","author":"M Debnath","year":"2022","journal-title":"Ann Neurosci"},{"issue":"10","key":"pone.0325624.ref008","doi-asserted-by":"crossref","first-page":"24629","DOI":"10.3390\/ijms161024629","article-title":"Genetics Underlying Atypical Parkinsonism and Related Neurodegenerative Disorders","volume":"16","author":"SW Scholz","year":"2015","journal-title":"Int J Mol Sci"},{"issue":"4","key":"pone.0325624.ref009","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1534\/genetics.106.069047","article-title":"Environmental effects on gene expression phenotype have regional biases in the human genome","volume":"175","author":"JK Choi","year":"2007","journal-title":"Genetics"},{"issue":"5","key":"pone.0325624.ref010","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/mds.26512","article-title":"Environmental and occupational risk factors for progressive supranuclear palsy: Case-control study","volume":"31","author":"I Litvan","year":"2016","journal-title":"Mov Disord"},{"issue":"2","key":"pone.0325624.ref011","doi-asserted-by":"crossref","first-page":"103","DOI":"10.14802\/jmd.20173","article-title":"Environmental Risk Factors for Progressive Supranuclear Palsy","volume":"14","author":"HK Park","year":"2021","journal-title":"J Mov Disord"},{"issue":"2","key":"pone.0325624.ref012","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00401-016-1576-7","article-title":"Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci","volume":"132","author":"M Allen","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"1","key":"pone.0325624.ref013","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00401-024-02764-4","article-title":"DNA methylation patterns in the frontal lobe white matter of multiple system atrophy, Parkinson\u2019s disease, and progressive supranuclear palsy: a cross-comparative investigation","volume":"148","author":"M Murthy","year":"2024","journal-title":"Acta Neuropathol"},{"issue":"1","key":"pone.0325624.ref014","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1038\/s41467-018-05325-y","article-title":"Epigenome-wide DNA methylation profiling in Progressive Supranuclear Palsy reveals major changes at DLX1","volume":"9","author":"A Weber","year":"2018","journal-title":"Nat Commun"},{"issue":"3","key":"pone.0325624.ref015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11910-017-0733-2","article-title":"Neuroinflammation in Neurodegenerative Disorders-a Review","volume":"17","author":"M Schain","year":"2017","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"3","key":"pone.0325624.ref016","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Y Yoshiyama","year":"2007","journal-title":"Neuron"},{"issue":"1","key":"pone.0325624.ref017","doi-asserted-by":"crossref","first-page":"13276","DOI":"10.1038\/s41598-018-31517-z","article-title":"Cerebrospinal fluid concentrations of inflammatory markers in Parkinson\u2019s disease and atypical parkinsonian disorders","volume":"8","author":"S Hall","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"pone.0325624.ref018","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/jnen\/60.6.647","article-title":"Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration","volume":"60","author":"K Ishizawa","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"pone.0325624.ref019","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.nbd.2017.07.014","article-title":"Cytokine profiling in the prefrontal cortex of Parkinson\u2019s Disease and Multiple System Atrophy patients","volume":"106","author":"R Rydbirk","year":"2017","journal-title":"Neurobiol Dis"},{"key":"pone.0325624.ref020","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3389\/fneur.2020.00665","article-title":"The Role of Magnetic Resonance Imaging for the Diagnosis of Atypical Parkinsonism","volume":"11","author":"L Chougar","year":"2020","journal-title":"Front Neurol"},{"issue":"7","key":"pone.0325624.ref021","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jnnp-2020-325549","article-title":"Neuroinflammation predicts disease progression in progressive supranuclear palsy","volume":"92","author":"M Malpetti","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"pone.0325624.ref022","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1093\/brain\/awl021","article-title":"Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy","volume":"129","author":"DC Paviour","year":"2006","journal-title":"Brain"},{"issue":"3","key":"pone.0325624.ref023","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.parkreldis.2011.10.013","article-title":"Rates of brain atrophy and clinical decline over 6 and 12-month intervals in PSP: determining sample size for treatment trials","volume":"18","author":"JL Whitwell","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"pone.0325624.ref024","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/biom13020218","article-title":"Retinal Structure Abnormalities in Parkinson\u2019s Disease and Atypical Parkinsonism","volume":"13","author":"X Ma","year":"2023","journal-title":"Biomolecules"},{"issue":"6","key":"pone.0325624.ref025","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria","volume":"32","author":"GU H\u00f6glinger","year":"2017","journal-title":"Mov Disord"},{"issue":"6","key":"pone.0325624.ref026","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/mds.29005","article-title":"The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy","volume":"37","author":"GK Wenning","year":"2022","journal-title":"Mov Disord"},{"issue":"5","key":"pone.0325624.ref027","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"MJ Armstrong","year":"2013","journal-title":"Neurology"},{"key":"pone.0325624.ref028","doi-asserted-by":"crossref","first-page":"101995","DOI":"10.1016\/j.scr.2020.101995","article-title":"Generation of induced pluripotent stem cells (NIMHi002-A and NIMHi003-A) from two sporadic Parkinson\u2019s disease patient of East Indian ethnicity","volume":"49","author":"I Datta","year":"2020","journal-title":"Stem Cell Res"},{"issue":"3","key":"pone.0325624.ref029","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1529-8027.2010.00271.x","article-title":"Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study","volume":"15","author":"G Lauria","year":"2010","journal-title":"J Peripher Nerv Syst"},{"issue":"7","key":"pone.0325624.ref030","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1021\/acschemneuro.2c00019","article-title":"Fibrinogen and Complement Factor H Are Promising CSF Protein Biomarkers for Parkinson\u2019s Disease with Cognitive Impairment\u2500A Proteomics-ELISA-Based Study","volume":"13","author":"A Naskar","year":"2022","journal-title":"ACS Chem Neurosci"},{"issue":"5","key":"pone.0325624.ref031","doi-asserted-by":"crossref","first-page":"665","DOI":"10.5664\/jcsm.6576","article-title":"AASM Scoring Manual Updates for 2017 (Version 2.4)","volume":"13","author":"RB Berry","year":"2017","journal-title":"J Clin Sleep Med"},{"issue":"6","key":"pone.0325624.ref032","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.3390\/app14062491","article-title":"Optical Coherence Tomography as a Biomarker in the Differential Diagnosis between Parkinson\u2019s Disease and Atypical Parkinsonian Syndromes: A Narrative Review","volume":"14","author":"S Karatzetzou","year":"2024","journal-title":"Applied Sciences"},{"key":"pone.0325624.ref033","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an international community of software platform partners","volume":"95","author":"PA Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"8","key":"pone.0325624.ref034","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1093\/brain\/awad105","article-title":"Progression of atypical parkinsonian syndromes: PROSPECT-M-UK study implications for clinical trials","volume":"146","author":"D Street","year":"2023","journal-title":"Brain"},{"key":"pone.0325624.ref035","doi-asserted-by":"crossref","first-page":"105296","DOI":"10.1016\/j.parkreldis.2023.105296","article-title":"New insights from a multi-ethnic Asian progressive supranuclear palsy cohort","volume":"108","author":"S-Y Lim","year":"2023","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"pone.0325624.ref036","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s13023-024-03168-z","article-title":"Progressive Supranuclear palsy (PSP) disease progression, management, and healthcare resource utilization: a retrospective observational study in the US and Canada","volume":"19","author":"E Nysetvold","year":"2024","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"pone.0325624.ref037","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209585","article-title":"CSF Proteomics in Patients With Progressive Supranuclear Palsy","volume":"103","author":"A Wise","year":"2024","journal-title":"Neurology"},{"issue":"1","key":"pone.0325624.ref038","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jalz.2019.06.4947","article-title":"The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodology","volume":"16","author":"B Boeve","year":"2020","journal-title":"Alzheimers Dement"},{"issue":"4","key":"pone.0325624.ref039","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/mds.29740","article-title":"Novel Insights into the Genetic Basis of Progressive Supranuclear Palsy in Asian-Indian Population","volume":"39","author":"S Dey","year":"2024","journal-title":"Mov Disord"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0325624","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T17:24:18Z","timestamp":1750958658000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0325624"}},"subtitle":[],"editor":[{"given":"Jennifer","family":"Tucker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0325624","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,26]]}}}